National seroepidemiological study of COVID-19 after the initial rollout of vaccines: Before and at the peak of the Omicron-dominant period in Japan.

Takeshi Arashiro,Satoru Arai,Ryo Kinoshita,Kanako Otani,Sho Miyamoto,Daisuke Yoneoka,Taro Kamigaki,Hiromizu Takahashi,Hiromi Hibino,Mai Okuyama,Ai Hayashi,Fuka Kikuchi,Saeko Morino,Sayaka Takanashi,Takaji Wakita,Keiko Tanaka-Taya,Tadaki Suzuki,Motoi Suzuki

Influenza and other respiratory viruses（2023）

引用 6|浏览15

暂无评分

摘要

Before Omicron, the cumulative burden was >10 times lower in Japan (2.2%) compared with the US (33%), the UK (25%), or global estimates (45%), but most developed antibodies owing to vaccination.

查看译文

关键词

Japan,coronavirus disease 2019 (COVID‐19),humoral immunity,seroepidemiologic studies,severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2),vaccines

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要